Ambarella Inc 's (NASDAQ:AMBA) Vice President of Marketing, Christopher Day, has sold a total of 2,904 ordinary shares of the company, according to a recent SEC filing. The transaction, which took place on October 3, 2024, was executed at a price of $58.0 per share, resulting in a total sale value of $168,432.
The sale has adjusted Day's holdings in the semiconductor company, leaving him with a total of 18,466 ordinary shares following the transaction. The nature of the ownership is reported as direct.
Ambarella Inc, based in Santa Clara, California, specializes in semiconductors and related devices, and is known for its high-definition video compression and image processing products.
Investors often monitor the buying and selling activities of company insiders as it can provide insights into the company's performance and insider perspectives on the stock's value. However, it's important to note that there can be various reasons for an executive to sell shares, and such transactions do not always indicate the executive's belief about the company's future performance.
For those interested in following the company's insider transactions, Ambarella's stock can be tracked on the NASDAQ under the ticker symbol AMBA.
In other recent news, Ambarella Inc. has reported a 17% sequential increase in revenue to $63.7 million in the second quarter of fiscal year 2025, exceeding consensus estimates. The company's non-GAAP earnings per share were at a loss of $0.13, surpassing the anticipated loss of $0.19 per share. Ambarella is ramping up production of the CV5 family and expects the CV7 family to enter production by the end of fiscal year 2025.
Craig-Hallum has raised its price target on Ambarella's stock to $85.00, maintaining a Buy rating, while KeyBanc and TD Cowen maintained their respective Sector Weight and Hold ratings. These decisions follow Ambarella's announcement of better-than-expected financial results for the second quarter and a positive outlook for the third quarter.
Furthermore, Ambarella is experiencing gains from new product introductions with higher average selling prices, specifically the CV5 product. The company's cash and marketable securities stood at $219.8 million by the end of Q2. These are recent developments that could significantly impact the company's future performance.
InvestingPro Insights
To provide additional context to Christopher Day's recent stock sale, let's examine some key financial metrics and insights from InvestingPro for Ambarella Inc (NASDAQ:AMBA).
As of the latest data, Ambarella has a market capitalization of $2.32 billion. The company's stock has shown some volatility, with a 16.98% price return over the past six months, despite a year-to-date decline of 6.72%. This volatility aligns with an InvestingPro Tip indicating that AMBA's stock price movements are quite volatile.
From a financial health perspective, Ambarella holds more cash than debt on its balance sheet, and its liquid assets exceed short-term obligations. These factors suggest a solid financial foundation, which could provide some reassurance to investors in light of the insider sale.
However, it's worth noting that Ambarella is not currently profitable, with a negative P/E ratio of -13.03. The company's revenue for the last twelve months stands at $220.41 million, with a significant revenue growth decline of -24.18% over the same period. Despite this, 13 analysts have revised their earnings upwards for the upcoming period, indicating some optimism about future performance.
Ambarella is trading at a high revenue valuation multiple, which could be a point of consideration for value-oriented investors. The company does not pay a dividend to shareholders, focusing instead on growth and reinvestment.
For readers seeking a more comprehensive analysis, InvestingPro offers additional tips and insights. In fact, there are 8 more InvestingPro Tips available for Ambarella, which could provide valuable context for understanding the company's financial position and market performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.